rs3731684

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_021815.5(SLC5A7):​c.741+18C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.107 in 1,595,768 control chromosomes in the GnomAD database, including 10,120 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.13 ( 1471 hom., cov: 32)
Exomes 𝑓: 0.10 ( 8649 hom. )

Consequence

SLC5A7
NM_021815.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.325

Publications

5 publications found
Variant links:
Genes affected
SLC5A7 (HGNC:14025): (solute carrier family 5 member 7) This gene encodes a sodium ion- and chloride ion-dependent high-affinity transporter that mediates choline uptake for acetylcholine synthesis in cholinergic neurons. The protein transports choline from the extracellular space into presynaptic terminals for synthesis into acetylcholine. Increased choline uptake results from increased density of this protein in synaptosomal plasma membranes in response to depolarization of cholinergic terminals. Dysfunction of cholinergic signaling has been implicated in various disorders including depression, attention-deficit disorder, and schizophrenia. An allelic variant of this gene is associated with autosomal dominant distal hereditary motor neuronopathy type VIIA. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2015]
SLC5A7 Gene-Disease associations (from GenCC):
  • neuronopathy, distal hereditary motor, type 7A
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
  • congenital myasthenic syndrome 20
    Inheritance: AR Classification: STRONG Submitted by: G2P, Ambry Genetics, PanelApp Australia, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • distal hereditary motor neuropathy type 7
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • presynaptic congenital myasthenic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 2-108002058-C-T is Benign according to our data. Variant chr2-108002058-C-T is described in ClinVar as Benign. ClinVar VariationId is 261429.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.181 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC5A7NM_021815.5 linkc.741+18C>T intron_variant Intron 6 of 8 ENST00000264047.3 NP_068587.1 Q9GZV3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC5A7ENST00000264047.3 linkc.741+18C>T intron_variant Intron 6 of 8 1 NM_021815.5 ENSP00000264047.2 Q9GZV3
SLC5A7ENST00000409059.5 linkc.741+18C>T intron_variant Intron 6 of 8 1 ENSP00000387346.1 Q9GZV3

Frequencies

GnomAD3 genomes
AF:
0.130
AC:
19724
AN:
152080
Hom.:
1464
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.173
Gnomad AMI
AF:
0.242
Gnomad AMR
AF:
0.187
Gnomad ASJ
AF:
0.0524
Gnomad EAS
AF:
0.145
Gnomad SAS
AF:
0.0389
Gnomad FIN
AF:
0.137
Gnomad MID
AF:
0.0538
Gnomad NFE
AF:
0.0977
Gnomad OTH
AF:
0.117
GnomAD2 exomes
AF:
0.123
AC:
29596
AN:
241268
AF XY:
0.113
show subpopulations
Gnomad AFR exome
AF:
0.177
Gnomad AMR exome
AF:
0.251
Gnomad ASJ exome
AF:
0.0591
Gnomad EAS exome
AF:
0.155
Gnomad FIN exome
AF:
0.139
Gnomad NFE exome
AF:
0.0974
Gnomad OTH exome
AF:
0.105
GnomAD4 exome
AF:
0.104
AC:
150273
AN:
1443570
Hom.:
8649
Cov.:
30
AF XY:
0.101
AC XY:
72435
AN XY:
715574
show subpopulations
African (AFR)
AF:
0.177
AC:
5822
AN:
32836
American (AMR)
AF:
0.243
AC:
10309
AN:
42364
Ashkenazi Jewish (ASJ)
AF:
0.0544
AC:
1382
AN:
25418
East Asian (EAS)
AF:
0.135
AC:
5298
AN:
39374
South Asian (SAS)
AF:
0.0338
AC:
2827
AN:
83702
European-Finnish (FIN)
AF:
0.130
AC:
6952
AN:
53288
Middle Eastern (MID)
AF:
0.0427
AC:
241
AN:
5650
European-Non Finnish (NFE)
AF:
0.101
AC:
111527
AN:
1101310
Other (OTH)
AF:
0.0992
AC:
5915
AN:
59628
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
5724
11448
17173
22897
28621
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4288
8576
12864
17152
21440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.130
AC:
19765
AN:
152198
Hom.:
1471
Cov.:
32
AF XY:
0.130
AC XY:
9685
AN XY:
74418
show subpopulations
African (AFR)
AF:
0.174
AC:
7211
AN:
41512
American (AMR)
AF:
0.187
AC:
2863
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0524
AC:
182
AN:
3470
East Asian (EAS)
AF:
0.145
AC:
751
AN:
5168
South Asian (SAS)
AF:
0.0385
AC:
186
AN:
4830
European-Finnish (FIN)
AF:
0.137
AC:
1448
AN:
10594
Middle Eastern (MID)
AF:
0.0578
AC:
17
AN:
294
European-Non Finnish (NFE)
AF:
0.0977
AC:
6643
AN:
68010
Other (OTH)
AF:
0.115
AC:
244
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
891
1782
2673
3564
4455
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
202
404
606
808
1010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.112
Hom.:
1738
Bravo
AF:
0.139
Asia WGS
AF:
0.100
AC:
346
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Sep 11, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Neuronopathy, distal hereditary motor, type 7A;C4310694:Congenital myasthenic syndrome 20 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
5.2
DANN
Benign
0.51
PhyloP100
-0.33
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3731684; hg19: chr2-108618514; COSMIC: COSV50888956; API